Rising incidence of breast cancer: relationship to stage and receptor status
- PMID: 2319611
- DOI: 10.1093/jnci/82.8.693
Rising incidence of breast cancer: relationship to stage and receptor status
Abstract
We used the population-based tumor registry of Kaiser Permanente in the United States (Portland, OR) to analyze breast cancer incidence from 1960 to 1985. Overall, incidence rose 45% during this period. The largest increases occurred in women 60 years of age or older (74%) and in those 45-59 (36%). The rate in women aged 20-44 has remained essentially unchanged. Localized and regional disease showed similar increases. Review of medical records revealed that only a small portion of this increase was likely to result from increased screening activities. From the increased availability of receptor assays in a large proportion of cases since the mid-1970s, we observed that incidence of estrogen receptor-negative cancers rose 22%-27% between the mid-1970s and the mid-1980s. In contrast, incidence of estrogen receptor-positive tumors increased an average of 131% in the same period, perhaps implicating hormonal factors in the rising incidence of breast cancer.
Similar articles
-
Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.J Natl Cancer Inst. 2007 Aug 1;99(15):1152-61. doi: 10.1093/jnci/djm059. Epub 2007 Jul 24. J Natl Cancer Inst. 2007. PMID: 17652280
-
Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.J Natl Cancer Inst Monogr. 2006;(36):7-15. doi: 10.1093/jncimonographs/lgj003. J Natl Cancer Inst Monogr. 2006. PMID: 17032888
-
Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1028-33. doi: 10.1158/1055-9965.EPI-07-0726. Epub 2008 May 7. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18463402
-
Breast cancer statistics, 2013.CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62. doi: 10.3322/caac.21203. Epub 2013 Oct 1. CA Cancer J Clin. 2014. PMID: 24114568 Review.
-
The "epidemic" of breast cancer in the U.S.--determining the factors.Oncology (Williston Park). 1996 Apr;10(4):453-62; discussion 462, 464, 470-2. Oncology (Williston Park). 1996. PMID: 8723277 Review.
Cited by
-
Nutrition and breast cancer risk: can an effect via insulin resistance be demonstrated?Breast Cancer Res Treat. 1996;38(3):239-46. doi: 10.1007/BF01806141. Breast Cancer Res Treat. 1996. PMID: 8739075 Review.
-
Pesticides--how research has succeeded and failed in informing policy: DDT and the link with breast cancer.Environ Health Perspect. 1995 Sep;103 Suppl 6(Suppl 6):87-91. doi: 10.1289/ehp.95103s687. Environ Health Perspect. 1995. PMID: 8549499 Free PMC article.
-
Recent trends in breast cancer incidence, mortality, and mammography.Breast Cancer Res Treat. 1993 Nov;28(2):97-106. doi: 10.1007/BF00666422. Breast Cancer Res Treat. 1993. PMID: 8173073 Review.
-
Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin.Breast Cancer Res. 2007;9(4):108. doi: 10.1186/bcr1736. Breast Cancer Res. 2007. PMID: 17666116 Free PMC article.
-
Identification and assessment of endocrine disruptors: limitations of in vivo and in vitro assays.Environ Health Perspect. 1998 Apr;106 Suppl 2(Suppl 2):577-82. doi: 10.1289/ehp.98106577. Environ Health Perspect. 1998. PMID: 9599705 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical